Clinical trials
Treatment clinical trials
Below are recruiting treatment clinical trials, each written for real people, not researchers. We’re tracking 8,312 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT03740893RecruitingPhase 2
Test drug to block DNA damage in triple-negative breast cancer
This Phase 2 trial studies a treatment given around the time of breast surgery to help shrink or control residual (remaining) triple-negative breast cancer. It also checks biomarkers (lab signals) to understand who benefits, with some people receiving anti–PD-L1 immunotherapy and some not.
Bournemouth, DorsetAges 18 years+ - NCT06704191RecruitingPhase 1/Phase 2
Bladder cancer treatment at home
This trial tests whether patients with early-stage bladder cancer can safely receive their usual bladder chemotherapy or immunotherapy at home instead of in the clinic. It aims to make treatment more convenient while keeping it effective.
Jacksonville, FloridaAges 18 years+ - NCT06693687Recruiting
Smartphone program to catch cancer treatment side effects early
This study tests a program called ApricityCare that uses your smartphone to help catch and manage side effects early. It is for people with cancer who are starting or continuing treatment that goes through the bloodstream.
Houston, TexasAges 18 years+ - NCT06704945RecruitingPhase 3
Skipping armpit surgery after good chemo response
This trial tests whether it's safe to skip armpit surgery in people whose breast cancer has responded well to chemotherapy and whose lymph nodes appear cancer-free on ultrasound. It aims to reduce side effects like arm swelling while still controlling the cancer.
SeoulAges 19 years+ - NCT06698822RecruitingPhase 2
Tofacitinib cream for early-stage cutaneous T-cell lymphoma
This trial is testing a cream called tofacitinib (a type of medicine that helps calm the immune system) for people with early-stage cutaneous T-cell lymphoma (CTCL). The goal is to see if it helps shrink or control the skin lesions safely.
Houston, TexasAges 18 years+ - NCT06702670RecruitingPhase 2/Phase 3
Anticholinergics for cervical edema in labor
This trial tests if a medication (diphenhydramine) can help reduce swelling in the cervix during labor for first-time mothers. It may make labor progress more smoothly.
Houston, TexasAges 18 years+ - NCT06694740RecruitingPhase 2/Phase 3
Interferon gamma for immune recovery in the ICU
This trial tests if a drug called interferon gamma can help boost the immune system of patients in the ICU who are fighting serious infections. It is for adults who are on a breathing machine and have low immune function.
ParisAges 18 years+ - NCT06698510Recruiting
Arpraziquantel for schistosomiasis in young children
This study tests a new medicine called arpraziquantel to treat schistosomiasis (a disease from parasites in water) in young children aged 2 to 5. It aims to see if giving this treatment in communities where the disease is common is safe and helpful.
AbidjanAges 2 years–4.9 years - NCT06687421Recruiting
Precision medicine for high-risk prostate cancer
This study aims to use precision medicine (tailored treatment based on your specific cancer) for men at high risk of prostate cancer. It may help doctors choose the best treatment for you.
UmeåAges 18 years+ - NCT05667506RecruitingPhase 1/Phase 2
Check CNCT19 cell therapy for relapsed childhood ALL
This early-stage trial tests a personalized immune-cell treatment called CNCT19 in children and teens whose leukemia (ALL) has come back or not responded to prior therapy. It may help the immune system recognize and attack leukemia cells that carry CD19.
Hefei, AnhuiAges 3–18 - NCT06277063Recruiting
Nerve-stimulation device for headache in children and young adults
This trial tests if a gentle nerve-stimulating device worn on the neck (called nVNS) can prevent and treat common headaches like migraine, cluster, and tension-type headaches in children and young adults. If you often get headaches and want a drug-free option, this might help.
Guangzhou, GuangdongAges 7–20 - NCT05939167RecruitingPhase 1/Phase 2
Stem cell treatment study for people with late-stage HIV
This Phase 1/2 study tests whether mesenchymal stem cells can help people with HIV who have lower immune cell counts. You would join a treatment plan and follow study rules closely, while the researchers track safety and early signs of benefit.
BeijingAges 18–65 - NCT06692114Recruiting
Deep brain stimulation for obsessive-compulsive disorder
This trial tests whether deep transcranial magnetic stimulation (a non-invasive brain stimulation technique) can help treat obsessive-compulsive disorder (OCD) in people who haven't improved enough with standard treatments like medication or therapy.
Shanghai, Shanghai MunicipalityAges 18–50 - NCT06684769Recruiting
Chitosan brush and enamel proteins for gum treatment
This trial tests a new way to clean deep gum pockets at the base of molars using a chitosan brush and enamel proteins. It's for people who still have gum problems after standard treatment.
RigaAges 18 years+ - NCT06692036Enrolling by invitation
Blood filtering for septic shock
This trial tests a special blood-filtering method (adaptive blood purification) for people with septic shock caused by a severe infection. It aims to see if this treatment can help control inflammation and improve recovery in the ICU.
Beijing, Beijing MunicipalityAges 18–82 - NCT06683235Enrolling by invitation
Flaxseed for Type 2 Diabetes in Mexico
This trial tests if flaxseed can help control blood sugar in adults with type 2 diabetes. You may be able to join if you have diabetes that is not well-controlled and live in Oaxaca.
Oaxaca City, OaxacaAges 30–70 - NCT06688838Enrolling by invitation
JAK inhibitor for Blau syndrome
This trial tests a new oral drug that blocks inflammation in people with Blau syndrome, a rare genetic condition causing joint, eye, and skin problems. The goal is to see if the drug can reduce symptoms and improve quality of life.
Wuhan, HubeiAges Any age - NCT06692582Recruiting
Saltwater rinse for treating gum disease
This study tests whether rinsing your mouth with a special saltwater solution (electrolyzed water) can help treat gum disease. It's for people who have advanced gum disease and want to try a simple, gentle addition to regular care.
LjubljanaAges 18–80 - NCT06686680Recruiting
Shockwave therapy for knee arthritis after ACL repair
This study tests whether shockwave therapy can help knee pain and function in people who developed knee osteoarthritis after an ACL reconstruction. If you had ACL surgery at least a year ago and still have knee pain, this treatment might offer a new option without surgery.
Cambridge, MassachusettsAges 18–55 - NCT06690840RecruitingPhase 2
Atezolizumab plus chemo for advanced triple-negative breast cancer
This trial tests atezolizumab (an immunotherapy) plus chemotherapy to activate immune cells in people with triple-negative breast cancer that has spread or cannot be removed. It is for those who have had immunotherapy before during early treatment but not for advanced disease.
Monza, MonzaAges 18 years+ - NCT06684522RecruitingEarly Phase 1
Upadacitinib for stubborn eyelid dermatitis
This study tests if the medication upadacitinib can help people whose eyelid rash has not improved with prescription creams. It's for adults who have had eyelid dermatitis for at least two months and have tried at least one prescribed cream that didn't work.
Chicago, IllinoisAges 18–70 - NCT06681896Recruiting
Exercise rehabilitation for heart microvessel disease
This trial tests a supervised exercise program for people with chest pain caused by tiny heart blood vessel problems (microvascular dysfunction). It aims to see if exercise can improve symptoms and heart function.
BathAges 18 years+ - NCT06689514RecruitingEarly Phase 1
Tranilast for enlarged prostate (medium to large volume)
This trial tests a drug called Tranilast to see if it can improve urinary symptoms caused by an enlarged prostate. It focuses on men with moderate to severe symptoms and a prostate size greater than 40 mL.
Shanghai, Outside U.S./CanadaAges 55–75 - NCT06686355RecruitingPhase 2
Yiqilishui formula for sepsis-related heart problems
This trial tests a Chinese herbal formula called Yiqilishui in people with sepsis who have developed heart muscle weakness. It aims to see if the formula can help improve heart function.
BeijingAges 50–85
Hear when a new Treatment trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for treatment?
- Yes. Clin2 currently lists 8,312 recruiting treatment studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a treatment trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a treatment trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.